Epidemiological studies have highlighted the role of arterial stiffness as a risk factor for development of cardiovascular (CV) diseases. Moreover, aortic stiffness has been shown to be a significant predictive factor of all-cause and CV mortality in different populations including patients with endstage renal disease. Pulse-wave velocity (PWV) is the most widely used technique to assess arterial stiffness. Although PWV can be measured on any artery or between any arterial sites, only carotid-to-femoral PWV, representing stiffness of the aorta and iliofemoral axes, has been shown to have predictive value for morbidity and mortality. The several available commercial devices differ according to the type of signal ( pressure, distension, flow) or by recording both sites simultaneously or using ECG synchronization. It is also possible to directly measure arterial diameter changes during the cardiac cycle and link them to local pulse-pressure changes, which provides the pressure-diameter relationship and stress-strain relationship if arterial wall thickness is also measured. These techniques are based on high-precision vascular echo tracking or magnetic resonance imaging and applanation tonometry. This paper summarizes the basic principles of arterial haemodynamics and various methodologies to assess stiffness and the latest consensus recommendations for clinical applications.
I N T RO D U C T I O N
Cardiovascular (CV) disease is one of the most frequent causes of morbidity and mortality in industrialized countries, and their major cause in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD) [1, 2] . The main CV complications are heart failure, myocardial infarction, stroke and peripheral artery disease. The CV-disease continuum of these morbid events progresses through target-organ damage including left ventricular hypertrophy (LVH), atherosclerotic plaque formation, arterial stiffening, endothelial dysfunction and inflammation [3] . These mechanisms present early as subclinical organ damage, can be identified before overt clinical manifestations and can be used as surrogate markers significantly associated with the future risk of clinical events, as they are reliable substitutes for a clinical event endpoint [3] . Several markers of CV organ damage have been associated with the risk of all-cause or CV mortality in patients with ESRD; the most relevant being LVH, carotid artery intima media thickness, endothelial dysfunction, arterial stiffness, arterial calcifications and ankle-brachial systolic blood pressure (BP) ratio [4] [5] [6] [7] [8] . To individualize risk assessment and risk-reduction strategies, organ damage should be sought. Ideally, such methods need to be safe, noninvasive, rapid, inexpensive, reliable and reproducible with good sensitivity and specificity (Table 1) [3] . Although very appealing, identification of early vascular damage through these surrogate markers has not been validated versus more conservative approaches.
Epidemiological and clinical results demonstrated that damage of large conduit arteries is a major contributing factor associated with the high incidence of CV diseases [4] [5] [6] [7] . Many studies emphasized the impact of arterial stiffness on the development of these CV complications, and as a strong and independent predictor of CV and all-cause mortality [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] (Table 2) . Premature vascular ageing, characterized by aortic and large central artery stiffening associated with arterial outward remodelling, is observed with progression of CKD and in ESRD [7, [21] [22] [23] [24] .
The roles of arterial stiffness in physiology and pathophysiology were recently detailed in several reviews [23, 25, 26] and herein the basic principles are only briefly summarized. This review focuses on the methodological issues of standardization of arterial stiffness parameters, as a basis for establishing high-quality systematic data collection in the framework of the European Renal and Cardiovascular Medicine (EURECAm) registry. To guarantee high-quality measurements, the EURECA-m registry created a data validation centre at Hôpital Manhès, France, where all measurements are to be sent by registry-participating investigators.
D E F I N I T I O N S O F S T I F F N E S S PA R A M E T E R S
The arterial system has two main functions: to assure adequate blood flow to tissues and organs, i.e. 'conduit function'; and a 'cushioning or dampening function'. The latter has two facets: transforming cyclic blood flow in the aorta into a continuous capillary flow; and dampening arterial pressure oscillations, thereby limiting their transmission to the microcirculation [23, 27, 28] . The efficiency of these functions depends on the stiffness and geometry of the aorta and central arteries, and Table 1 . Principal techniques for clinical use and evaluation of CV endorgan damage in CKD/ESRD
• Heart structure and function Echocardiography: detection of LV hypertrophy; left atrial dilation; valves dysfunction; systolic and diastolic dysfunction (Doppler). ECG should be part of the assessment (arrhythmias, blocks, ischaemia), calcium score (CT scan)
• Arterial structure and function Ultrasound scanning of carotid arteries: detection of vascular hypertrophy (intima media thickness >900 μm), or the presence of atherosclerotic plaques and stenosis (Doppler).
Doppler unit and blood pressure manometer for ankle-brachial systolic pressure index (A/Bix): A/Bix < 0.9 reflects occlusive peripheral artery disease and advanced atherosclerosis; A/Bix >1.4 is associated with incompressible calcified arteries.
Arterial stiffness: aortic stiffness [carotid-femoral pulse-wave velocity, the gold standard >12 m/s (in 2007), >10 m/s (in 2013)]; regional and local stiffness via changes in vessel diameter as a function of local pressure changes (ultrasound scanning coupled with tonometry).
Central pulse-wave analysis and determination of central BP pressure and wave reflections: High fidelity Millar strain gauge transducer and transfer function (Sphygmocor ® ).
• Several other methods difficult to use for clinical and routine investigation, or not methodologically standardized are available: MRI, endothelial dysfunction, coronary calcifications. 
N D T P E R S P E C T I V E S
A r t e r i a l s t i f f n e s s m e a s u r e m e n t rigidity of successive arterial segments. Both functions are linked, since efficient flow distribution to organs is dependent on energy storage during diastole as artery distends, i.e. their elastic properties, which, in return, buffer pressure and flow. Arteries are distensible, i.e. they expand during systole as a consequence of increased stroke volume, and recoil during diastolic runoff. These geometric-volume transformations are caused by arterial BP changes with stiffness expressing the vasculature (total or segmental) volume as a function of a given transmural pressure ( pressure-volume relationships). The ability of arteries to accommodate the stroke volume can be described in terms of compliance, distensibility or its reciprocal, arterial stiffness. Compliance (C) is defined as a volume change (ΔV, strain) for a given pressure change (ΔP, stress): C = ΔV/ΔP. To compare structures with different initial dimensions, compliance can be expressed relative to the initial volume (V) as distensibility (D): D = ΔV/V × ΔP. The reciprocal value of distensibility is stiffness (V*ΔP/ΔV). Unlike compliance or distensibility, which provide information about the 'elasticity' of the artery as a hollow structure, the elastic incremental (Young's) modulus (E inc ) provides information on the intrinsic elastic properties of the biomaterials that compose the arterial wall independent of vessel geometry, because it is normalized to vessel-wall thickness [23, 27, 28] .
The pressure-volume relationship is nonlinear: at low distending pressure, the tension is borne by distensible elastin fibres, whereas at a high distending pressure, the tension is progressively transferred and borne by much stiffer collagen fibres. Thus, the arterial wall gets stiffer and more 'resistant' to distension with increased arterial BP. Obviously, the function reflecting this phenomenon is to avoid excessive distension of vessels due to increased BP. The most typical clinical consequence of arterial stiffening is a steep pressure-volume relationship, with increased systolic BP (SBP) during ventricular ejection and decreased diastolic BP (DBP) during diastolic runoff, resulting in high pulse pressure (PP) [25] and excessive variability [23, 29] .
During ventricular contraction, part of the stroke volume is momentarily stored in the aorta and central arteries, stretching their walls because of rising local BP. The arterial pressure wave generated in the aorta (forward or incident wave) is propagated to arteries throughout the body and is partly reflected back towards the aorta (reflected pressure wave). Arterial stiffness determines the propagation velocity of the pressure wave [ pulse-wave velocity, PWV = (1/D) 0.5 ]. PWV propagates bidirectionally, from the proximal aorta towards peripheral vessels and back. When aortic stiffness is low, the reflected pressure wave is delayed enough to impact on central arteries during end-systole and diastole, thereby increasing the aortic pressure during early diastole but not systole. This situation is physiologically advantageous, because the higher DBP boosts coronary perfusion, without increasing the LV pressure load. Increased arterial stiffening disrupts the desirable timing. With faster PWV, the reflected waves return earlier, impacting on the central arteries during systole rather than diastole, amplifying aortic and ventricular systolic pressures and reducing aortic diastolic pressure. By favouring early wave reflections, arterial rigidity increases peak-and end-systolic pressures in the ascending aorta, thereby raising myocardial pressure load (LVH) and oxygen consumption, and decreasing DBP and subendocardial blood flow [25, 27, 30, 31] .
The arterial system is heterogeneous. First, the most elastic arteries are close to the heart, and stiffness increases with increasing distance from the heart. As a consequence, PWV increases progressively from the ascending aorta to the peripheral muscular conduit arteries, generating an arterial stiffness gradient of great physiological importance because it acts as a selective filter that regulates pulsatile pressure transmission to the microcirculation. The stiffness gradient, together with aortic geometry changes (tapering), local arterial branching and lumen narrowing, creates an impedance mismatch causing partial pressure-wave reflections generated at the transition between these segments, limiting pulsatile energy transmission downstream to the microcirculation that is not designed to bear it [23, 28, [32] [33] [34] .
Thus, arterial stiffness enables the arterial tree to cope with the systolic ejection volume due to the distension of compliant large arteries during systole and to relay cardiac contraction during diastolic runoff, when the large arteries return to their initial dimensions and help maintain blood flow. The aorta is the major capacitive element of the arterial system, and a major determinant of the amplitude of the incident/forward pressure wave. Aortic stiffening also influences the reflected pressure-wave return and the overlap of incident and reflected pressure waves. Thus, aortic stiffening, through its direct effects on the forward pressure-wave amplitude and reflected wave timing, has multiple effects on LV structure and function. Aortic stiffness is a major determinant of increased SBP and PP, thereby increasing LV afterload and contributing to LVH, increased oxygen consumption and impaired ventricular relaxation. The lower DBP, which is another consequence of arterial stiffening and modified wave reflection timing, is responsible for decreased coronary perfusion pressure. Increased aortic stiffness also diminishes the stiffness gradient causing pressure overload to smaller arterial segments and microcirculation with concomitant perturbations (capillary rarefaction, inward remodeling of small arteries) [23, [28] [29] [30] [31] [32] [33] [34] .
M E A S U R E M E N T O F A R T E R I A L S T I F F N E S S
Because the methodological issues concerning the measurement of various stiffness indices and their clinical applications were recently published and updated in detail [23, 25, 26, [35] [36] [37] [38] , herein we only briefly mention the most relevant for arterial stiffness measurements in clinical practice and research.
Several direct or indirect methods have been proposed to quantify arterial stiffness. Among the former, the most widely used is the propagative model based on PWV measurement, introduced in engineering in the late 19th century and to physiology in 1922 by Bramwell and Hill [39] . The 'elastic' properties of the arterial wall determine the velocity of pulsewave propagation, PWV = (V*ΔP/ΔV*ρ) 0.5, derived from Moens-Korteweg equation PWV = (E*h/D*ρ) 0.5 , where ρ is the density, E is the elastic modulus, h is the wall thickness and D is the diameter [27] . PWV determination implies measuring
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tained by the application of a pressure transducer on the artery of interest. A crucial point is the reference part of the curve, for which time is calculated. The general consensus is to use the systolic upstroke as the reference point: the foot of the wave. The latter's identification relies on different algorithms, with the intersecting tangent method being the most popular and the most reliable [35, 40, 41] . As an alternative to pressure wave, any other physiological wave can be used, with special attention given to the time and amplitude response, which conditions the accuracy of the pulse-transit time. As typical transit time is 30-80 ms, 2 ms (500 Hz) precision represents 2-8% of transit time. Ranked by order of their precision, pressure transducers, Doppler flow and distension by echo tracking can be considered relatively equivalent.
To express transit times as PWV, it is necessary to measure the distance between recording sites. The preferred sites are the common carotid artery and the femoral artery in the groin, and the direct carotid-to-femoral distance was used in almost all epidemiological studies. Usually, the pathway is measured transcutaneously, using a tape measure or caliper. Because the pulse wave travels in opposite directions once it bifurcates at the brachiocephalic trunk, direct measurement between sites leads to a systematic PWV overestimation. Many corrections have been proposed, such as subtracting carotid site to sternal notch distance from the overall distance, which provides values closer to invasive measurements but increases errors due to duplicate distance measurements (Figure 1 ). Using Doppler probes positioned at the suprasternal notch and close to the umbilicus to measure aortic PWV targets a more linear vessel segment with no curvatures or bifurcations and avoids the above-mentioned difficulties, but is less precise concerning flow signal acquisition site.
To overcome these ambiguities, the scientific community has accepted a standard definition of distance, combining the better precision of carotid-femoral site distance measurement, and the better accuracy compared with invasive techniques. The formula is PWV = 0.8*L/ΔT where L is direct distance and ΔT is transit time (Figure 1 ). Of all currently used distances, 80% of the direct carotid-femoral distance (L*0.8) is apparently the most accurate, as it generates fewer errors by measuring distance only once [38, 42] .
MRI appears to be the gold standard for measurement of PWV and has been used for absolute PWV calibration [42] . Indeed, it can detect both distension and/or flow with impressive image reconstruction, and allows precise measurement of true path length. Nevertheless, MRI is limited with 20-ms imprecision concerning transit time. Although partial compensation is obtained by repeated measurements on many cycles, it is an important limitation when the examined arterial path is short or PWV very high.
Relative values of different PWV-assessment methods.
Carotid-femoral PWV is the most widely used index of arterial stiffness, which has demonstrated predictive value for CV outcomes, independent of and better than classical risk factors in several longitudinal, follow-up studies, conducted in different geographical locations and including various populations (Table 2) [43, 44] . PWV can also be measured on carotidradial or femoral-tibial arterial segments. However, the predictive values of those more peripheral PWV measurements are unknown, nor is there any epidemiological evidence for derivative technique, e.g. brachial-ankle PWV or single-point PWV measurements.
Prerequisites for PWV measurements. The guidelines for measuring PWV are the same as for any other physiological measurement to obtain the best reproducibility. The subject must rest in supine position for at least 5-10 min, in a room maintained at a standardized temperature (ideally temperature-controlled), and to better interpret PWV measurements, BP must be accurately measured within minutes of recording PWV. Baseline PWV should be the mean of at least two consecutive measurements necessary to appreciate spontaneous variations. Excellent ECG and carotid and femoral pulse records are mandatory. Repeated measurements over the time must be obtained under the same conditions, e.g. at the same time of day, before a meal and without any stimulant (coffee or tobacco) [26, 45, 46] , and adjusted for similar BP. Under good conditions, time-repeated PWV measurement is good (8-10% of the mean value) [35, 46, 47] . These constraining requirements are mandatory for haemodynamics studies but are rarely met in clinical settings. To what extent deviations from these optimal conditions affect the validity of measurement has not yet been studied.
Several devices are commercially available and extensively used worldwide (Table 3 ). The first marketed was the Complior System ® (Artech, Les Lilas, France), which simultaneously records arterial pulse waves at carotid and femoral sites, through mechanotransducer probes [46] . The 
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A r t e r i a l s t i f f n e s s m e a s u r e m e n t SphygmoCor ® system (ArtCor, Sydney, Australia) [47] has become popular because it also measures central (aortic or carotid) BP, and has been used in large clinical trials and population surveys [48] . It uses a large-band piezoelectric probe and successively records arterial pulse (carotid then femoral), with both signals being synchronized to the same ECG R wave, which imposes verifying that the heart rate is similar at the moment of each recording to avoid any heart rate-induced disturbance. The most recent device is the Pulsepen ® (Diatecne, Milano, Italy) [49] , which uses successive recordings of arterial pulse waves synchronized to ECG. It also allows carotid artery pulse-wave analysis ( proxy for aortic BP), directly measured without any transfer function.
Related techniques warrant being mentioned, notably brachial-ankle PWV (baPWV), based on oscillations in cuffs placed on the brachial artery and calf, measuring the time delay between both signals. This method is popular in Asia because it avoids exposing the groin. The pulse-wave pathway is still being discussed, and the validity of baPWV is still contested [50] . The Qkd, based on ambulatory BP measurements (ABPM) (Diasys ® , Novacor, Rueil Malmaison, France) [51] , and the speed of Korotkoff sound propagation compared with the ECG R-wave were validated in one large population for its predictive value, but it is very sensitive to heart rate and the precise relationships between QKD interval (Q: QRS complex on ECG; K: Korotkoff sound and D: diastole) and aortic PWV are still being debated.
Single-point PWV based on oscillometric measures (Arteriograph) [52] , and many other astute recent techniques (Vicorder) making use of different ingeniously developed concepts are based on assumptions that require further investigation before being recommended (Table 3) .
PWV directly measures regional arterial stiffness for the territory located between the two measurement sites. In this respect, it differs from indirect methods relying on circulation models, e.g. the 'Windkessel' model which is based on exponential DBP decay with its exponential proportional to stiffness. This model can be made more complex by using two exponential functions: one for large arteries (C1) and the other for small arteries (C2) [53, 54] .
Another indirect technique, uses aortic characteristic impedance, is the minimal impedance for higher frequencies of pressure-and-flow harmonics which is proportional to PWV. It requires flow-and-pressure measurements at the aortic root. Characteristic impedance is rarely used alone, as it is hampered by the difficulty of obtaining reliable noninvasive data for aortic flow and pressure [55] .
Also available are rigidity estimates derived from BP measurement, e.g. ABPM-derived arterial stiffness index (1/ slope of the SBP-DBP relationship) [56] or crude brachial PP. Although these values reflect arterial stiffness, they are not surrogates for direct artery-stiffness measurements and aortic (carotid-femoral) PWV, which is considered the gold standard [35, 42] .
Measurements of local arterial stiffness. While PWV is a measure of arterial stiffness over given segment, it is also possible to directly measure arterial dimension changes during the cardiac cycle and link them to local PP oscillations: local stiffness. This approach is straightforward and provides the pressure-diameter relationship, the stress-strain relationship if wall thickness is also measured and, thus, provides stiffness indexes at any given BP level. These techniques are based on high-precision vascular echo tracking and applanation tonometry [21, 57] (Figure 2 ). It is mandatory that BP be measured locally at the echo-tracking site of diameter changes because it may differ from brachial BP because of wave reflection [57, 58] . Measurement of stiffness using the pressure-diameter relationship is not as validated equally well as PWV in terms of predicting CV events. Multiple reasons may explain the lack of validation: first it was introduced later; second, it is more technically challenging, and thus, cohorts are smaller; and third, because stiffness is the ratio of BP-to-dimension changes, measurement errors of BP and arterial diameter changes are amplified. Nevertheless, measurement of local stiffness using echo-tracking devices remains a useful tool for 
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clinical research, especially because these values take into account other very important parameters, e.g. artery diameter and thickness [36] .
Measurements of central BP. Analysis of the central BP waveform and amplitude (in the carotid artery or proximal aorta) is a further method frequently used to assess arterial stiffness indirectly. Aortic rigidity together with stroke volume and ejection velocity is determinants of arterial pressure-wave amplitude, influencing SBP, DBP and aortic PP. While pressurewave analysis represents an important advancement in the assessment of large artery properties, its interpretation as a measure of stiffness is an oversimplification. The principal 'stiffness' parameter assessed concerns the effect of reflected pressure waves on pressure waveform shape and amplitude, estimated in absolute terms, i.e. augmented PP in mm Hg or in relative terms, i.e. Augmentation index (Aix in % of PP) [57, 58] . Considered to be a stiffness index, the relationships of Aix with arterial rigidity are more complex, depending on the overlap between forward and reflected pressure waves. That overlap is influenced by the relationships between transit time of pressure waves from the aorta to reflecting sites and back (depending on PWV and traveling distance) and duration of LV ejection (heart rate) [23, 43, 58] .
CO N C L U S I O N
Arterial stiffness measurements are obtained with numerous methods and devices but they differ largely according to their physical bases, simplicity of use and characteristics of the measured parameter. A gold standard method would require (i) direct parameter measurement without any intermediate model;
(ii) providing a precise image of the patient's physiological condition and of independent predictive value for events; (iii) being easily performed in routine and being accepted by numerous research groups worldwide and based on a broad range of patients in different populations. As previously noted by the European Expert Consensus on Arterial Stiffness [35, 36] , the 'gold standard' method remains carotid-femoral PWV, mainly because it has been validated based on clinical and epidemiological studies on different populations, whose reference values were been published [35, 36, 42] . Much work remains to be done to demonstrate that patient care including PWV measurement provides better protection than standard care, as claimed once [59] .
Because PWV measurement still requires technical expertise, many manufacturers have proposed alternative techniques based on assumptions. The techniques are not interchangeable and agreement limits among them are wide. One very important point is the possibility to replace gold standard methods by novel techniques. The usual way to compare techniques is to provide correlations and Bland and Altman plots. New alternative approaches are usually based on additional assumptions (leading to oversimplifications), that are usually related to gold standard PWV with R² values of 0.4-0.7, which reflect very imperfect agreement. Most are currently pending epidemiological validation and lack solid results, whereas gold standard PWV has constantly been independently associated with outcomes [35, 36, 60] . Weak correlations with gold standard values are not sufficient to assert equivalence. Even epidemiological evidence is not qualifying, because the parameter's significance is often debatable, interpretation is complex and it is never comparable to the gold standard for predictive value. Independent assessment of the abilities of devices to measure arterial stiffness accurately will be unavoidable in the future.
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